BRAF and neoplasm: The analysis of the mechanical properties according to the presence of mutations in KRAS and BRAF genes that determine constitutive activation of the corresponding proteins and across tumour grade showed that patients with mutations in KRAS gene had a slightly higher relative stiffening, while a stronger relative increase is related to different tumour grade (G3 > G2).